Literature DB >> 19996605

Allelic heterogeneity in genetic association meta-analysis: an application to DTNBP1 and schizophrenia.

Brion S Maher1, Mark A Reimers, Brien P Riley, Kenneth S Kendler.   

Abstract

BACKGROUND/AIMS: Meta-analysis of genetic association studies is a useful approach when individual investigations do not yield studywise significant results but the evidence across studies is modest and homogeneous. Current meta-analysis methods account for heterogeneity by down-weighting studies as a function of between-study variance. We contend that current approaches may obscure interesting phenomena in genetic association data. However, an appropriate approach to examining heterogeneity across studies is lacking.
METHODS: We develop a novel approach, based on the EM algorithm, to detect allelic heterogeneity, identify subpopulations and assign studies to those subpopulations. We then apply these methods to the association between DTNBP1 and schizophrenia (Scz), one of the most studied relationships in complex disease genetics. We examined 32 published and unpublished population and family-based association studies containing up to 14 SNPs spanning the DTNBP1 locus.
RESULTS: We explored heterogeneity in several ways including meta-regression and approaches aimed at exploring the mixture of heterogeneous studies at a particular SNP. We found significant evidence for a mixture of association distributions at multiple loci.
CONCLUSION: We propose a novel approach that is broadly applicable and may be useful in large scale genetic association meta-analyses to detect significant allelic heterogeneity. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996605      PMCID: PMC7077085          DOI: 10.1159/000264445

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  37 in total

1.  The log likelihood ratio test (the G-test); methods and tables for tests of heterogeneity in contingency tables.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1957-06       Impact factor: 1.670

2.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

3.  A haplotype-based 'haplotype relative risk' approach to detecting allelic associations.

Authors:  J D Terwilliger; J Ott
Journal:  Hum Hered       Date:  1992       Impact factor: 0.444

4.  No gene is an island: the flip-flop phenomenon.

Authors:  Ping-I Lin; Jeffery M Vance; Margaret A Pericak-Vance; Eden R Martin
Journal:  Am J Hum Genet       Date:  2007-01-22       Impact factor: 11.025

Review 5.  Non-replication and inconsistency in the genome-wide association setting.

Authors:  John P A Ioannidis
Journal:  Hum Hered       Date:  2007-06-06       Impact factor: 0.444

6.  Genetic flip-flop without an accompanying change in linkage disequilibrium.

Authors:  Dmitri V Zaykin; Kyoko Shibata
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

7.  Empirical genomewide significance levels established by whole genome simulations.

Authors:  S Sawcer; H B Jones; D Judge; F Visser; A Compston; P N Goodfellow; D Clayton
Journal:  Genet Epidemiol       Date:  1997       Impact factor: 2.135

Review 8.  Support for schizophrenia vulnerability loci on chromosomes 6p and 8p from Irish families.

Authors:  R E Straub; C J MacLean; D Walsh; K S Kendler
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1996

9.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

10.  Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.

Authors:  Mousumi Mutsuddi; Derek W Morris; Skye G Waggoner; Mark J Daly; Edward M Scolnick; Pamela Sklar
Journal:  Am J Hum Genet       Date:  2006-10-03       Impact factor: 11.025

View more
  11 in total

1.  The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Authors:  Brion S Maher; Vladimir I Vladimirov; Shawn J Latendresse; Dawn L Thiselton; Rebecca McNamee; Moonsu Kang; Tim B Bigdeli; Xiangning Chen; Brien P Riley; John M Hettema; Howard Chilcoat; Christian Heidbreder; Pierandrea Muglia; E Lenn Murrelle; Danielle M Dick; Fazil Aliev; Arpana Agrawal; Howard J Edenberg; John Kramer; John Nurnberger; Jay A Tischfield; Bernie Devlin; Robert E Ferrell; Galina P Kirillova; Ralph E Tarter; Kenneth S Kendler; Michael M Vanyukov
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

Review 2.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

3.  Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice.

Authors:  Shalini Saggu; Tyrone D Cannon; J David Jentsch; Antonieta Lavin
Journal:  Schizophr Res       Date:  2013-03-06       Impact factor: 4.939

4.  No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample.

Authors:  Sarah E Bergen; Ayman H Fanous; Po-Hsiu Kuo; Brandon K Wormley; F Anthony O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

5.  XRCC5 as a risk gene for alcohol dependence: evidence from a genome-wide gene-set-based analysis and follow-up studies in Drosophila and humans.

Authors:  Dilafruz Juraeva; Jens Treutlein; Henrike Scholz; Josef Frank; Franziska Degenhardt; Sven Cichon; Monika Ridinger; Manuel Mattheisen; Stephanie H Witt; Maren Lang; Wolfgang H Sommer; Per Hoffmann; Stefan Herms; Norbert Wodarz; Michael Soyka; Peter Zill; Wolfgang Maier; Elisabeth Jünger; Wolfgang Gaebel; Norbert Dahmen; Norbert Scherbaum; Christine Schmäl; Michael Steffens; Susanne Lucae; Marcus Ising; Michael N Smolka; Ulrich S Zimmermann; Bertram Müller-Myhsok; Markus M Nöthen; Karl Mann; Falk Kiefer; Rainer Spanagel; Benedikt Brors; Marcella Rietschel
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

6.  The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.

Authors:  Brien Riley; Po-Hsiu Kuo; Brion S Maher; Ayman H Fanous; Jingchun Sun; Brandon Wormley; F Anthony O'Neill; Dermot Walsh; Zhongming Zhao; Kenneth S Kendler
Journal:  Schizophr Res       Date:  2009-10-02       Impact factor: 4.939

Review 7.  Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.

Authors:  Cristina A Ghiani; Esteban C Dell'Angelica
Journal:  ASN Neuro       Date:  2011-05-27       Impact factor: 4.146

8.  Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness.

Authors:  T Bernard Bigdeli; Brion S Maher; Zhongming Zhao; Edwin J C G van den Oord; Dawn L Thiselton; Jingchun Sun; Bradley T Webb; Richard L Amdur; Brandon Wormley; Francis A O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler; Ayman H Fanous
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

Review 9.  From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia.

Authors:  Ariel Cariaga-Martinez; Jerónimo Saiz-Ruiz; Raúl Alelú-Paz
Journal:  Front Neurosci       Date:  2016-05-11       Impact factor: 4.677

10.  Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.

Authors:  Emilio Sacchetti; Catia Scassellati; Alessandra Minelli; Paolo Valsecchi; Cristian Bonvicini; Patrizio Pasqualetti; Alessandro Galluzzo; Rosaria Pioli; Massimo Gennarelli
Journal:  BMC Med Genet       Date:  2013-03-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.